Company
United StatesPublic company, NASDAQ: AGIOAgios Pharmaceuticals, INC. (NASDAQ: AGIO), Cambridge, MA – FDA Inspections
Inspection records and compliance data for Agios Pharmaceuticals, INC. in Cambridge, Massachusetts. 2 FDA inspections on record, last inspected September 16, 2021. Publicly traded as NASDAQ: AGIO.
Company Profile
This profile covers Agios Pharmaceuticals, INC. based in Cambridge, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected March 9, 2018. Last inspected September 16, 2021.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 16, 2021 | NAI | Human Drugs · Bioresearch Monitoring | 1152494 |
| March 9, 2018 | NAI | Human Drugs · Bioresearch Monitoring | 1046031 |
FDA documents
EIRs (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Agios Pharmaceuticals, INC.
Stock ticker
AGIO
Exchange
NASDAQ
Share price
$31.76
Market cap
$1.9B
Price as of
November 13, 2026
FEI Number
3012469070
Address
88 Sidney St, Cambridge, Massachusetts 02139, United States
Country
United States
ID: 56e211c0-dde4-4267-a2fa-29bed2c57c05